GlaxoSmithKline Witty Says will Keep Consumer Business

LONDON, Feb 7 (Reuters) - GlaxoSmithKline Plc’s incoming chief executive Andrew Witty said on Thursday he had no intention of selling the group’s consumer healthcare business.

MORE ON THIS TOPIC